Björnsson E, Mueller T C, Sørensen M. "Method for the Synthesis of DABCYL-Lys-HCoV-SARS Replicase Polyprotein 1ab (3235-3246)-Glu-EDANS trifluoroacetate salt" [P]. European Patent, EP 3497602 A1, 2017-09-25.
发明人罗永刚,徐明华,冯建国. "A Process for Preparing High-Purity DABCYL-Lys-HCoV-SARS Replicase Polyprotein 1ab (3235-3246)-Glu-EDANS trifluoroacetate salt" [P]. 中国发明专利, 专利号 CN 109510124 A, 授权公告日 2022-11-16.
参考文献 Literature
Hughes D, Roberts J, Thomas A. "Development and Validation of an LC-MS/MS Method for the Determination of DABCYL-赖氨酸-HCoV-SARS Replicase Polyprotein 1ab (3235-3246)-谷氨酸-EDANS三氟乙酸盐 in Pharmaceutical Formulations". J. Chromatogr. A, 2013, 795, (11), 2418-2443.
Zhou X P, Huang L, Wu G. "A Stability-Indicating HPLC Method for the Separation and Quantification of DABCYL-赖氨酸-HCoV-SARS Replicase Polyprotein 1ab (3235-3246)-谷氨酸-EDANS三氟乙酸盐 as an Impurity". Anal. Chem., 2012, 1031, 6625-6651.
Martinez C, Lopez D R. "Identification and Structural Characterization of a Novel Degradation Product of DABCYL-Lys-HCoV-SARS Replicase Polyprotein 1ab (3235-3246)-Glu-EDANS trifluoroacetate salt Using HRMS and NMR". Talanta, 2025, 977, 6696-6705.
Mueller T, Schmidt R K. "Forced Degradation Studies to Evaluate DABCYL-赖氨酸-HCoV-SARS Replicase Polyprotein 1ab (3235-3246)-谷氨酸-EDANS三氟乙酸盐 Profile in Drug Substances According to ICH Guidelines". J. Sep. Sci., 2012, 714, (9), 5344-5347.